https://www.live-feeds.com/feed/eli-lilly-launches-foundayo-weight-loss-pill-in-u-kContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/eli-lilly-launches-foundayo-weight-loss-pill-in-u-khttps://www.live-feeds.com/feed/eli-lilly-launches-foundayo-weight-loss-pill-in-u-k#u48522Wed, 26 Aug 2026 00:06:11 +0000Eli Lilly has launched its oral weight-loss drug, Foundayo, in the UK. The pill is intended for weight loss and is a daily diabetes medication. Foundayo is now available in UK pharmacies. This launch comes as Eli Lilly competes with Novo Nordisk in the weight-loss drug market. The UK launch is seen as a strategic move by Eli Lilly to expand its presence in the global weight-loss market.Why it mattersThe weight-loss drug market has seen significant activity with major pharmaceutical companies like Eli Lilly and Novo Nordisk competing for market share. Eli Lilly's Foundayo is expected to be